Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy

被引：6

作者：

Kerckhove, Nicolas ^{[1
,2
,3
]}

Selvy, Marie ^{[1
]}

Lambert, Celine ^{[2
]}

Gonneau, Coralie ^{[1
]}

Feydel, Gabrielle ^{[2
]}

Petorin, Caroline ^{[4
]}

Vimal-Baguet, Agnes ^{[4
]}

Melnikov, Sergey ^{[5
]}

Kullab, Sharif ^{[6
]}

Hebbar, Mohamed ^{[7
]}

Bouche, Olivier ^{[8
]}

Slimano, Florian ^{[9
]}

Bourgeois, Vincent ^{[10
]}

Lebrun-Ly, Valerie ^{[11
]}

Thuillier, Frederic ^{[11
]}

Mazard, Thibault ^{[12
]}

Tavan, David ^{[13
]}

Benmammar, Kheir Eddine ^{[14
]}

Monange, Brigitte ^{[14
]}

Ramdani, Mohamed ^{[15
]}

Pere-Verge, Denis ^{[16
]}

Huet-Penz, Floriane ^{[17
]}

Bedjaoui, Ahmed ^{[18
]}

Genty, Florent ^{[19
]}

Leyronnas, Cecile ^{[20
]}

Busserolles, Jerome ^{[1
,3
]}

Trevis, Sophie ^{[21
]}

Pinon, Vincent ^{[21
]}

Pezet, Denis ^{[22
]}

Balayssac, David ^{[1
,2
]}

机构：

[1] Univ Clermont Auvergne, INSERM U1107 NEURO DOL, Clermont Ferrand, France

[2] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, Clermont Ferrand, France

[3] Univ Clermont Auvergne, Inst Analgesia, Clermont Ferrand, France

[4] CHU Clermont Ferrand, Serv Oncol Digest, Clermont Ferrand, France

[5] Ctr Hosp St Flour, Serv Chirurg Gen & Viscerale, St Flour, France

[6] Ctr Hosp Moulins Yzeure, Serv Oncol, Moulins, France

[7] CHRU Lille, Serv Oncol, Lille, France

[8] Univ Reims, Serv Oncol Digest, CHU Reims, Reims, France

[9] Univ Reims, Serv Pharm, SFR CAP Sante, BioSpect,CHU Reims, Reims, France

[10] Ctr Hosp Boulogne Sur Mer, Serv Oncol Digest, Boulogne Sur Mer, France

[11] CHU Limoges, Serv Oncol, Limoges, France

[12] Univ Montpellier, INSERM, IRCM, ICM, Montpellier, France

[13] Infirmerie Protestante Lyon, Serv Gastroenterol, Caluire Et Cuire, France

[14] Ctr Hosp Emile Roux, Serv Oncol, Le Puy En Velay, France

[15] Ctr Hosp Beziers, Serv Gastroenterol, Beziers, France

[16] Ctr Hosp St Joseph St Luc, Serv Hepatogastroenterol, Lyon, France

[17] Ctr Hosp Alpes Leman, Serv Gastro Enterol, Contamine Sur Arve, France

[18] Ctr Hosp Intercommunal Hop Leman, Serv Gastroenterol, Thonon Les Bains, France

[19] Ctr Hosp Vichy, Serv Chirurg Digest & Viscerale, Vichy, France

[20] Grp Hosp Mutualiste Grenoble, Serv Oncol, Grenoble, France

[21] CHU Clermont Ferrand, Serv Pharm, Clermont Ferrand, France

[22] Univ Clermont Auvergne, CHU Clermont Ferrand, USC INRA 2018, INSERM,M2iSH, Clermont Ferrand, France

来源：

FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷

关键词：

chemotherapy-induced peripheral neuropathy; neuropathic pain; colorectal cancer; oxaliplatin; cluster analysis; NEUROTOXICITY; QUESTIONNAIRE; PREVENTION; GUIDELINES; RISK;

D O I：

10.3389/fphar.2021.744085

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in colorectal cancer survivors, a secondary analysis was designed to explore the possibility that different clusters of patients may co-exist among a cohort of patients with oxaliplatin-related CIPN. Other objectives were to characterize these clusters considering CIPN severity, anxiety, depression, health-related quality of life (HRQOL), patients' characteristics and oxaliplatin treatments. Among the 96 patients analyzed, three clusters were identified (cluster 1: 52, cluster 2: 34, and cluster 3: 10 patients). Clusters were significantly different according to CIPN severity and the proportion of neuropathic pain (cluster 1: low, cluster 2: intermediate, and cluster 3: high). Anxiety, depressive disorders and HRQOL alteration were lower in cluster 1 in comparison to clusters 2 and 3, but not different between clusters 2 and 3. This study underlines that patients with CIPN are not a homogenous group, and that CIPN severity is associated with psychological distress and a decline of HRQOL. Further studies are needed to explore the relation between clusters and CIPN management.

引用

页数：10

共 38 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2] Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin [J].

Alberti, P. ;

Rossi, E. ;

Cornblath, D. R. ;

Merkies, I. S. J. ;

Postma, T. J. ;

Frigeni, B. ;

Bruna, J. ;

Velasco, R. ;

Argyriou, A. A. ;

Kalofonos, H. P. ;

Psimaras, D. ;

Ricard, D. ;

Pace, A. ;

Galie, E. ;

Briani, C. ;

Dalla Torre, C. ;

Faber, C. G. ;

Lalisang, R. I. ;

Boogerd, W. ;

Brandsma, D. ;

Koeppen, S. ;

Hense, J. ;

Storey, D. ;

Kerrigan, S. ;

Schenone, A. ;

Fabbri, S. ;

Valsecchi, M. G. ;

Cavaletti, G. .

ANNALS OF ONCOLOGY, 2014, 25 (01) :257-264

[3] Platinum-drugs induced peripheral neurotoxicity: clinical course and preclinical evidence [J].

Alberti, Paola .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (06) :487-497

[4] Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy [J].

Aprile, Giuseppe ;

Ramoni, Marco ;

Keefe, Dorothy ;

Sonis, Stephen .

CANCER, 2008, 112 (02) :284-292

[5] Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk [J].

Bao, Ting ;

Basal, Coby ;

Seluzicki, Christina ;

Li, Susan Q. ;

Seidman, Andrew D. ;

Mao, Jun J. .

BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (02) :327-333

[6] A Quantitative Sensory Analysis of Peripheral Neuropathy in Colorectal Cancer and Its Exacerbation by Oxaliplatin Chemotherapy [J].

Barbosa, Mariana de Carvalho ;

Kosturakis, Alyssa K. ;

Eng, Cathy ;

Wendelschafer-Crabb, Gwen ;

Kennedy, William R. ;

Simone, Donald A. ;

Wang, Xin S. ;

Cleeland, Charles S. ;

Dougherty, Patrick M. .

CANCER RESEARCH, 2014, 74 (21) :5955-5962

[7] A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration [J].

Beijers, A. J. M. ;

Mols, F. ;

Vreugdenhil, G. .

SUPPORTIVE CARE IN CANCER, 2014, 22 (07) :1999-2007

[8] Classification of patients based on their evaluation of hospital outcomes: cluster analysis following a national survey in Norway [J].

Bjertnaes, Oyvind ;

Skudal, Kjersti Eeg ;

Iversen, Hilde Hestad .

BMC HEALTH SERVICES RESEARCH, 2013, 13

[9] The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients [J].

Bonhof, Cynthia S. ;

van de Poll-franse, Lonneke V. ;

Wasowicz, Dareczka K. ;

Beerepoot, Laurens V. ;

Vreugdenhil, Gerard ;

Mols, Floortje .

JOURNAL OF CANCER SURVIVORSHIP, 2021, 15 (02) :190-200

[10] Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry [J].

Bonhof, Cynthia S. ;

van de Poll-Franse, Lonneke V. ;

Vissers, Pauline A. J. ;

Wasowicz, Dareczka K. ;

Wegdam, Johannes A. ;

Revesz, Dora ;

Vreugdenhil, Gerard ;

Mols, Floortje .

PSYCHO-ONCOLOGY, 2019, 28 (09) :1926-1933

← 1 2 3 4 →